全文获取类型
收费全文 | 284650篇 |
免费 | 23765篇 |
国内免费 | 9255篇 |
专业分类
耳鼻咽喉 | 2394篇 |
儿科学 | 9376篇 |
妇产科学 | 1907篇 |
基础医学 | 24325篇 |
口腔科学 | 4665篇 |
临床医学 | 31984篇 |
内科学 | 73857篇 |
皮肤病学 | 3426篇 |
神经病学 | 28159篇 |
特种医学 | 8603篇 |
外国民族医学 | 14篇 |
外科学 | 22222篇 |
综合类 | 41439篇 |
现状与发展 | 41篇 |
一般理论 | 12篇 |
预防医学 | 21793篇 |
眼科学 | 2837篇 |
药学 | 20585篇 |
231篇 | |
中国医学 | 14084篇 |
肿瘤学 | 5716篇 |
出版年
2024年 | 853篇 |
2023年 | 5778篇 |
2022年 | 10232篇 |
2021年 | 14359篇 |
2020年 | 13871篇 |
2019年 | 10863篇 |
2018年 | 10621篇 |
2017年 | 10790篇 |
2016年 | 11233篇 |
2015年 | 10900篇 |
2014年 | 19706篇 |
2013年 | 21671篇 |
2012年 | 16575篇 |
2011年 | 17834篇 |
2010年 | 14234篇 |
2009年 | 13616篇 |
2008年 | 13453篇 |
2007年 | 13240篇 |
2006年 | 11771篇 |
2005年 | 9878篇 |
2004年 | 8403篇 |
2003年 | 7279篇 |
2002年 | 6171篇 |
2001年 | 5392篇 |
2000年 | 4477篇 |
1999年 | 3822篇 |
1998年 | 3517篇 |
1997年 | 3193篇 |
1996年 | 2904篇 |
1995年 | 2627篇 |
1994年 | 2407篇 |
1993年 | 1989篇 |
1992年 | 1901篇 |
1991年 | 1640篇 |
1990年 | 1322篇 |
1989年 | 1145篇 |
1988年 | 1057篇 |
1987年 | 946篇 |
1986年 | 834篇 |
1985年 | 1022篇 |
1984年 | 840篇 |
1983年 | 512篇 |
1982年 | 600篇 |
1981年 | 529篇 |
1980年 | 392篇 |
1979年 | 322篇 |
1978年 | 246篇 |
1977年 | 218篇 |
1976年 | 186篇 |
1975年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
171.
172.
173.
ObjectiveThe beneficial effects of carnitine supplementation on nonalcoholic fatty liver disease are unclear. We conducted a systematic review and meta-analysis to evaluate the effects of carnitine supplementation on liver function, lipid profile, body mass index, body weight, and homeostasis model assessment of insulin resistance in patients with nonalcoholic fatty liver disease.MethodsA comprehensive search of PubMed, Web of Science, Scopus, Cochrane Library, and Google Scholar databases were performed. Only randomized placebo-controlled human studies that examined the effects of carnitine supplementation on liver function, lipid profile, body mass index, body weight, and homeostasis model assessment of insulin resistance up to September 2019 were included. Fixed effects or random-effects models were applied to compute the pooled effect size. Heterogeneity assessments were performed using Cochran’s Q test and I-squared statistics. The quality of the studies was assessed using the Jaded scale.ResultsA total of 5 articles were selected, including 334 individuals (167 in control and 167 in intervention groups). The results demonstrated that carnitine supplementation significantly reduced homeostasis model assessment of insulin resistance (HOMA-IR) (WMD: −0.91; 95 % CI: −1.11, −0.72; p < 0.001, I2 = 0.0 %) and the levels of aspartate aminotransferase (AST) (WMD: −16.62; 95 % CI: −28.11, −5.14; IU/l; p = 0.005, I2 = 93.5 %), alanine aminotransferase (ALT) (WMD: -33.39; 95 % CI: −45.13, −21.66; IU/l; p < 0.001, I2 = 93.4 %), and triglycerides (TG) (WMD: −22.13; 95 % CI: −38.91, −5.34; mg/dl; p = 0.01; I2 = 0.0 %). However, the results of the pooled effect size did not show any significant effect of carnitine supplementation on body mass index (BMI) (WMD: 0.07; 95 % CI: −0.15, 0.29; p = 0.55; I2 = 0.0 %), body weight (WMD: −0.28; 95 % CI: −2.23, 1.68; p = 0.78; I2 = 45.7 %), the levels of gamma-glutamyl transferase (γGT) (WMD: −11.31; 95 % CI: −24.35, 1.73; IU/l; p = 0.09, I2 = 61.1 %), cholesterol (WMD: −13.58; 95 % CI: −46.77, 19.60; mg/dl; p = 0.42; I2 = 94.9 %), high-density lipoprotein-cholesterol (HDL-C) (WMD: 1.36; 95 % CI: −0.96, 3.68; mg/dl; p = 0.25; I2 = 64.7 %), and low density lipoprotein-cholesterol (LDL-C) (WMD: −14.85; 95 % CI: −45.43, 15.73; mg/dl; p = 0.34; I2 = 96.4 %).ConclusionsThis analysis shows that carnitine supplementation for patients with nonalcoholic fatty liver disease demonstrates a reduction in AST, ALT, TG levels and HOMA-IR. However, no significant effect of carnitine supplementation was observed on BMI, body weight, the levels of γGT, TC, HDL-cholesterol and LDL-cholesterol. 相似文献
174.
目的 分析2007-2017年浙江省24 388例罕见病住院病例特征,为制定罕见病防控策略提供依据。方法 收集2007-2017年浙江省10家三级甲等(三甲)医院罕见病住院病例资料和各年度住院数,进行描述性统计分析。结果 罕见病病例共24 388例,占住院总例数的2.69‰(24 388/9 054 201),病例数居前3位的疾病类型依次为"血液和造血器官疾病以及某些涉及免疫机能的异常"(占32.81%,8 001/24 388)、"先天性畸形、变形和染色体异常"(占24.87%,6 065/24 388)和"神经系统疾病"(占19.01%,4 635/24 388);2007-2017年罕见病病例数呈逐年增长趋势,年均增幅19.69%,而罕见病例数占同期住院总例数比例仅在2016-2017年明显上升,各类型罕见病时间分布呈不同特征;罕见病的病例数男女性别比为1.35:1(13 990/10 398),男女性别比最高的3类疾病依次为"消化系统疾病"(4.45:1,1 180/265)、"损伤、中毒和外因的某些其他后果"(3.51:1,281/80)和"神经系统疾病"(2.26:1,3 213/1 422);各年龄段罕见病类型、各类型罕见病年龄分布均呈不同特征;病例数居前10位的疾病占全部罕见病例数的53.55%(13 060/24 388),其中前3位疾病分别为成人粒细胞缺乏症(14.41%,3 515/24 388)、皮质基底核退化症(7.60%,1 854/24 388)和亨诺克-舍恩莱因紫癜(6.01%,1 466/24 388)。结论 本研究分析的浙江省2007-2017年24 388例罕见病住院病例的特征资料,是推动我国罕见病的研究、监测或登记数据库构建、制定防控策略的参考依据。 相似文献
175.
《Clinical therapeutics》2019,41(5):836-847
PurposeA role for the immune system in causing myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is long suspected, but few studies have looked for specific autoantibodies that might contribute to the symptoms. Our aim was to look for evidence of antibodies to neuronal proteins in patients with ME/CSF.MethodsSera samples from 50 patients and 50 healthy individuals were sent coded to the Neuroimmunology Laboratory in Oxford. Screening for antibody binding to neuronal tissue was performed on brain tissue and neuronal cultures. Specific serum antibodies were assessed by antigen-specific cell-based assays and radioimmunoassays. After antibody testing, the associations between seropositive status and clinical data were investigated.FindingsOverall, 8 patients and 11 participants were found to have some serum immunoreactivity toward neuronal or neuromuscular junction proteins, but only 1 patient and 2 participants had specific serum antibodies. Nevertheless, seropositive status in patients with ME was associated with shorter duration since onset and a more severe disease.ImplicationsThe results indicate no overall increased frequency of antibodies to neuronal proteins in ME/CSF and no evidence of a specific antibody that might be causative or contribute to clinical features in patients. However, the association of seropositive status with shorter duration of disease and more severe symptoms suggests a possible role of antibodies at onset in some patients and should be the focus of future studies. 相似文献
176.
177.
178.
《Journal of vascular and interventional radiology : JVIR》2019,30(6):781-789
Pelvic venous disorders (PeVDs) in women can present with chronic pelvic pain, lower-extremity and vulvar varicosities, lower-extremity swelling and pain, and left-flank pain and hematuria. Multiple evidence gaps exist related to PeVDs with the consequence that nonvascular specialists rarely consider the diagnosis. Recognizing this, the Society of Interventional Radiology Foundation funded a Research Consensus Panel to prioritize a research agenda to address these gaps. This paper presents the proceedings and recommendations from that Panel. 相似文献
179.
Miju Bae Sung Woon Chung Chung Won Lee Up Huh Min Su Kim Seung Hwan Song 《Asian journal of surgery / Asian Surgical Association》2019,42(1):235-239